Evaluation of the efficiency of different schemes of Pre-operative Analgesia in Oral Surgeries

Not Applicable

• Conditions: Pain, Postoperative; C23.888.592.612

• Registration Number: RBR-4b5dsg
• Lead Sponsor: Faculdade de Odontologia da Universidade Federal de Minas Gerais

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-21
• Last Update Posted: 29 May 2023
• Study Completion: 2023-06-30

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

For periodontal surgeries patients with periodontitis and need for open flap periodontal surgery for scaling and root planing; patients with good systemic health ASA I or II who do not make continuous use of any analgesic and anti-inflammatory medication could bring some kind of bias to the study outcomes; patients with absence of pain; for dental implant surgeries patients with need of bone-integrated dental implant diameter 3.5 mm or 3.75 mm height 10 or 13 mm with the site presenting 2 mm of keratinized gingiva and 10 mm of vertical bone and more than 5 mm of vestibular-lingual bone; patients with good systemic health ASA I or II who do not make continuous use of any analgesic and anti-inflammatory medication that could bring some kind of bias to the study outcomes; patients with absence of pain and signs of oral infection.

Exclusion Criteria

Pregnant or lactating mothers; asthmatics; history of allergy or intolerance to the drugs and other substances or materials used in the present research; patients with a history of kidney or liver problems; patients with blood dyscrasias; history of the use of drugs with analgesic or anti-inflammatory properties within 7 days before surgery; patients taking bisphosphonates and other anti-resorptive agents; cases in which the duration of the surgery or number of anesthetics exceeds the average time that will be standardized, trans or postoperative complications; patients who do not respond to the questionnaires.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected Outcome 1<br>decrease in postoperative pain; verification performed through the visual analogue scale (VAS) numbered from 0 to 10, where 0 means no pain and 10, maximum pain; evaluation performed at 1 hour, 6 hours, 24 hours, 48 hours and 72 hours after the end of the surgical procedure; a comparison will be made between the average pain of each group for each hour with a significance level of 5%.

Secondary Outcome Measures

Name	Time	Method
Expected outcome 2<br>decreased use of analgesic medication in the postoperative period; verified through the number of analgesic pills used by patients within a maximum period of 72 hours after the end of the surgical procedure.